Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghan M Heberton

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|November 6, 2019
Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: A retrospective cohort studyMeghan M Heberton, Shivani Tripathi, Michael Slade, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2021
Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patientsJonathan J Lo, Meghan M Heberton, Omar Pacha, et al.
Cancer Treatment and Research Communications|July 14, 2022
Periorbital edema associated with alpelisibElizabeth A Dao, Saira J George, Meghan M Heberton, et al.
Journal of Cutaneous Pathology|March 21, 2023
Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature reviewNa Niu, Meghan M Heberton, Zhenya Tang, et al.
Frontiers in Oncology|March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity ReactionPaul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Journal of Cutaneous Pathology|October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapyRiyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|November 6, 2019
Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: A retrospective cohort studyMeghan M Heberton, Shivani Tripathi, Michael Slade, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2021
Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patientsJonathan J Lo, Meghan M Heberton, Omar Pacha, et al.
Cancer Treatment and Research Communications|July 14, 2022
Periorbital edema associated with alpelisibElizabeth A Dao, Saira J George, Meghan M Heberton, et al.
Journal of Cutaneous Pathology|March 21, 2023
Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature reviewNa Niu, Meghan M Heberton, Zhenya Tang, et al.
Frontiers in Oncology|March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity ReactionPaul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Journal of Cutaneous Pathology|October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapyRiyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Pageof 1